+

WO2001053455A3 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides Download PDF

Info

Publication number
WO2001053455A3
WO2001053455A3 PCT/US2000/035017 US0035017W WO0153455A3 WO 2001053455 A3 WO2001053455 A3 WO 2001053455A3 US 0035017 W US0035017 W US 0035017W WO 0153455 A3 WO0153455 A3 WO 0153455A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
novel
present
Prior art date
Application number
PCT/US2000/035017
Other languages
French (fr)
Other versions
WO2001053455A2 (en
Inventor
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Original Assignee
Hyseq Inc
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/596,196 external-priority patent/US6586390B1/en
Priority claimed from US09/653,274 external-priority patent/US6635742B1/en
Application filed by Hyseq Inc, Y Tom Tang, Chenghua Liu, Radoje T Drmanac filed Critical Hyseq Inc
Priority to US10/296,115 priority Critical patent/US20040053248A1/en
Priority to EP00990304A priority patent/EP1254256A4/en
Priority to CA002395736A priority patent/CA2395736A1/en
Priority to AU27348/01A priority patent/AU2734801A/en
Publication of WO2001053455A2 publication Critical patent/WO2001053455A2/en
Priority to US10/128,558 priority patent/US20040219521A1/en
Publication of WO2001053455A3 publication Critical patent/WO2001053455A3/en
Priority to US10/243,552 priority patent/US20030224379A1/en
Priority to US10/302,689 priority patent/US20080050393A1/en
Priority to US10/496,905 priority patent/US20050192215A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
PCT/US2000/035017 1998-12-03 2000-12-22 Novel nucleic acids and polypeptides WO2001053455A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US10/296,115 US20040053248A1 (en) 2000-12-22 2000-12-22 Novel nucleic acids and polypeptides
EP00990304A EP1254256A4 (en) 1999-12-23 2000-12-22 NOVEL NUCLEIC ACID AND POLYPEPTIDE
CA002395736A CA2395736A1 (en) 1999-12-23 2000-12-22 Novel nucleic acids and polypeptides
AU27348/01A AU2734801A (en) 1999-12-23 2000-12-22 Novel nucleic acids and polypeptides
US10/128,558 US20040219521A1 (en) 2000-01-21 2002-04-22 Novel nucleic acids and polypeptides
US10/243,552 US20030224379A1 (en) 2000-01-21 2002-09-12 Novel nucleic acids and polypeptides
US10/302,689 US20080050393A1 (en) 1998-12-03 2002-11-22 Novel nucleic acids and polypeptides
US10/496,905 US20050192215A1 (en) 2000-01-21 2002-12-02 Methods and materials relating to novel polypeptides and polynucleotides

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US47127599A 1999-12-23 1999-12-23
US09/471,275 1999-12-23
US48872500A 2000-01-21 2000-01-21
US09/488,725 2000-01-21
US55231700A 2000-04-25 2000-04-25
US09/552,317 2000-04-25
US09/596,196 US6586390B1 (en) 2000-01-21 2000-06-17 Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides
US09/653,274 US6635742B1 (en) 2000-01-25 2000-08-31 Antibodies specific for semaphorin-like polypeptides

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US55231700A Continuation-In-Part 1999-12-23 2000-04-25
PCT/US2001/002687 Continuation-In-Part WO2001054477A2 (en) 1998-12-03 2001-01-25 Novel nucleic acids and polypeptides

Related Child Applications (4)

Application Number Title Priority Date Filing Date
US549901A Continuation-In-Part 2000-01-21 2001-12-03
US8464302A Continuation-In-Part 1998-12-03 2002-02-26
US10/128,558 Continuation-In-Part US20040219521A1 (en) 2000-01-21 2002-04-22 Novel nucleic acids and polypeptides
US10/243,552 Continuation-In-Part US20030224379A1 (en) 2000-01-21 2002-09-12 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
WO2001053455A2 WO2001053455A2 (en) 2001-07-26
WO2001053455A3 true WO2001053455A3 (en) 2002-05-02

Family

ID=27541704

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/035017 WO2001053455A2 (en) 1998-12-03 2000-12-22 Novel nucleic acids and polypeptides

Country Status (1)

Country Link
WO (1) WO2001053455A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7344880B2 (en) 1998-04-24 2008-03-18 Genentech, Inc. Nucleic acid encoding PRO9912 polypeptides
US7414112B2 (en) 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
PT1623990E (en) * 1999-03-08 2008-03-18 Genentech Inc Compositions and methods for the treatment of tumours
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US6242419B1 (en) * 1999-03-25 2001-06-05 Genesis Research & Development Corporation Ltd. Compositions isolated from stromal cells and methods for their use
US7282570B2 (en) 1999-04-20 2007-10-16 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CA2374612A1 (en) 1999-05-28 2000-12-07 Immunex Corporation Novel murine and human kinases
AU1238201A (en) * 1999-10-27 2001-05-08 Millennium Pharmaceuticals, Inc. Novel molecules and the card-related protein family and uses thereof
CA2492049A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7365157B2 (en) 1999-12-23 2008-04-29 Genentech, Inc. PRO9912 polypeptides
US7164001B2 (en) 2000-01-20 2007-01-16 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
AU2001257195B2 (en) 2000-04-25 2006-10-05 Lexicon Pharmaceuticals, Inc. Novel human kinase proteins and polynucleotides encoding the same
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
AU2001274923A1 (en) * 2000-05-23 2001-12-03 Lexicon Genetics Incorporated Novel human thrombospondin-like proteins and polynucleotides encoding the same
AU2001264819A1 (en) * 2000-05-26 2001-12-11 Indiana University Advanced Research And Technology Institute Placc, a novel human c-c chemokine isolated from placenta
US20020019028A1 (en) * 2000-06-13 2002-02-14 Kabir Chaturvedi Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US7094587B2 (en) 2000-06-27 2006-08-22 Millennium Pharmaceuticals, Inc. 16002 Molecules and uses therefor
AU2001268053A1 (en) * 2000-07-05 2002-01-14 Eli Lilly And Company Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2001283062A1 (en) 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
AU2001290240A1 (en) 2000-09-19 2002-04-02 Kyowa Hakko Kogyo Co. Ltd. Polypeptide having phospholipase a2 actiivty
WO2002026997A2 (en) * 2000-09-26 2002-04-04 Ceptyr, Inc. Dsp-16 dual-specificity phosphatase
CA2423677A1 (en) * 2000-10-04 2002-04-11 Curagen Corporation Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
US6911336B2 (en) * 2000-10-18 2005-06-28 Immunex Corporation GNK interacting amino acid decarboxylase and methods of use thereof
US20040171109A1 (en) * 2000-11-10 2004-09-02 Dominik Haudenschild IL-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
WO2002057460A2 (en) 2000-12-20 2002-07-25 Bristol-Myers Squibb Company Polynucleotides encoding human phosphatases
US20020102637A1 (en) * 2000-12-21 2002-08-01 Chunhua Yan Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
JP2005508141A (en) 2001-05-25 2005-03-31 セローノ ジェネティクス インスティテュート ソシエテ アニニム Human cDNAs and proteins and their use
US20030135035A1 (en) * 2001-08-09 2003-07-17 Mark Shannon Human ZZAP1 protein
JP2005504546A (en) * 2001-08-17 2005-02-17 インサイト・ゲノミックス・インコーポレイテッド Intracellular signaling molecules
JP3740043B2 (en) 2001-09-14 2006-01-25 アテナ ダイアグナスティクス，インコーポレイテッド Diagnosis and treatment of spinocerebellar degeneration (EAOH) based on aprataxin gene
US20040253597A1 (en) * 2001-09-17 2004-12-16 Atsushi Nakanishi Novel protein and dna thereof
US20050123925A1 (en) * 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20030228319A1 (en) * 2002-04-16 2003-12-11 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20040248138A1 (en) * 2001-11-01 2004-12-09 Mark Shannon Human angiomotin-like protein 1
US7151162B2 (en) 2001-12-06 2006-12-19 The University Of Children's Hospital Of Both Cantons Of Basel Nuclear protein
US20040025194A1 (en) * 2002-02-22 2004-02-05 Board Of Trustees Of The University Of Illinois Beta chain-associated regulator of apoptosis
US7662924B2 (en) 2002-02-22 2010-02-16 The Board Of Trustees Of The University Of Illinois Beta chain-associated regulator of apoptosis
CA2478572A1 (en) * 2002-03-14 2003-09-18 Fanny Coignard Variants of human kallikrein-2 and kallikrein-3 and uses thereof
WO2003087408A2 (en) * 2002-04-05 2003-10-23 University Court Of The University Of Edinburgh Schizophrenia associated genes
EP2305710A3 (en) 2002-06-03 2013-05-29 Genentech, Inc. Synthetic antibody phage libraries
AU2003261102A1 (en) * 2002-06-28 2004-01-19 Imclone Systems Incorporated Novel polynucleotide and polypeptide sequences and uses thereof
AU2003251202A1 (en) * 2002-08-14 2004-03-03 Lg Life Sciences Ltd. Gene families associated with stomach cancer
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
JP4634372B2 (en) 2003-03-27 2011-02-16 ピーティーシー セラピューティクス，インコーポレーテッド Methods for identifying compounds that target tRNA splicing endonucleases and their use as antifungal agents
EP2319318A3 (en) 2003-03-27 2011-08-17 PTC Therapeutics, Inc. Methods of identifying compounds that target TRNA splicing endonuclease and uses of said compounds as anti-proliferative agents
JP4990621B2 (en) 2003-07-02 2012-08-01 ピーティーシー セラピューティクス，インコーポレーテッド RNA processing protein complex and use thereof
WO2005031359A2 (en) * 2003-09-27 2005-04-07 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase rnpep (rnpep)
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
RU2392966C2 (en) 2004-07-20 2010-06-27 Дженентек, Инк. Angiopoietic angiopoietin-like protein 4 inhibitors, in combinations and application
BRPI0513477A (en) 2004-07-20 2008-05-06 Genentech Inc Angiotensin-like protein 4 compositions and processes
DE102004059781A1 (en) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Use of serum / glucocorticoid-regulated kinase
US9540427B2 (en) * 2007-05-30 2017-01-10 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Peptide-based stat inhibitor
BRPI1014858A2 (en) 2009-03-30 2017-03-28 Acceleron Pharma Inc "bmp-alk3 antagonists and uses to promote bone growth"
EP2878335B1 (en) 2013-11-10 2018-01-03 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3093043B1 (en) 2015-05-13 2018-11-14 Brainsgate Ltd. Implant and delivery system for neural stimulator
CA3163139A1 (en) * 2018-12-27 2020-07-02 Vivienne I. Rebel Compositions and methods for treating cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EST [online] NATIONAL HUMAN GENOME INSTITUTE, (BETHESDA, MD, USA); 13 October 1999 (1999-10-13), JIA ET AL.: "SGAP: The skeletal genome anatomy project", XP002944982, Database accession no. AW068570 *
See also references of EP1254256A4 *
WATSON ET AL.: "The science used in the recombinant DNA industry. Recombinant DNA; A short course", 1983, W.H. FREEMAN AND COMPANY, NEW YORK, XP002944983 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation

Also Published As

Publication number Publication date
WO2001053455A2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2003054152A3 (en) Novel nucleic acids and polypeptides
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2003023013A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
WO2004009834A3 (en) Novel nucleic acids and secreted polypeptides
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2001079449A3 (en) Novel nucleic acids and polypeptides
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2003080795A8 (en) Novel nucleic acids and secreted polypeptides
WO2001002571A3 (en) An interleukin-1 receptor antagonist and uses thereof
WO2005049806A3 (en) Novel nucleic acids and polypeptides
WO2002044340A3 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2395736

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000990304

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000990304

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10296115

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000990304

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载